Welcome to Patriot Path
Diabetic Retinopathy and VA Disability
Licensed Physician, MD | Patriot Path Medical Team
Specializing in VA disability evaluations and independent medical opinions • Last updated: October 2026
Board-certified physicians specializing in VA disability documentation. Meet our clinicians → • Our review process →
Diabetic retinopathy is damage to the blood vessels of the retina, the light-sensing tissue at the back of the eye, caused by diabetes. The American Diabetes Association's 2026 Standards of Care call it "a highly specific neurovascular complication of diabetes". Eye doctors stage it on an international five-stage scale: no apparent retinopathy; mild, moderate and severe nonproliferative retinopathy (NPDR); and proliferative retinopathy (PDR), when abnormal new blood vessels grow. Diabetic macular edema, swelling of the central retina, is graded separately and can develop at any stage from mild nonproliferative to proliferative retinopathy.
It can be silent. The ADA cautions that "people with vision-threatening retinopathy may be asymptomatic", which is why the dilated eye exam matters. When symptoms do show up, the National Eye Institute describes trouble reading or seeing faraway objects, changes that may come and go, blurry vision from macular edema, and dark floating spots or cobweb-like streaks when a vessel bleeds into the eye; the NEI says it is important to get treatment right away, even if the spots clear up on their own. The National Eye Institute also says eye doctors "can check for diabetic retinopathy as part of a dilated eye exam", and that if your eye doctor thinks you may have severe diabetic retinopathy or diabetic macular edema (DME), "they may do a test called a fluorescein angiogram." A 2018 review calls spectral domain optical coherence tomography (SD-OCT) "the cornerstone of clinical assessment of DME" (PMID 30451174). A 2021 study describes VA's teleretinal screening program, which "uses nonmydriatic fundus photography to screen for diabetic retinopathy in primary care clinics" (PMID 34297906), and the ADA states that retinal photographs "are not a substitute for dilated comprehensive eye exams".
VA does not rate the stage. The rating schedule's code for diabetic retinopathy is Diagnostic Code 6040, rated on one of two measures, whichever gives the higher rating: your corrected vision and visual fields, or the number of documented treatment visits your eyes needed in the past 12 months. If neither reaches the first tier, the retinopathy is 0 percent, and Note (1) to the diabetes code, DC 7913, counts it as part of the diabetic process.
In the decisions we read, the link to diabetes was not where service connection for diabetic retinopathy failed. Of the 28 Board decisions we reviewed for our companion guide, each of the four that denied service connection for diabetic retinopathy turned on a missing diagnosis or on diabetes that was not service connected, not on whether diabetes caused the retinopathy. That is our own sample, not a VA statistic, and Board decisions are "binding only with regard to the specific case decided" (38 CFR 20.1303). Whether a nexus letter would add anything to your claim is the subject of that guide, linked below.
Diabetic Retinopathy Ratings Under DC 6040
The rating schedule gave diabetic retinopathy its own diagnostic code, DC 6040, on May 13, 2018. Its whole entry in 38 C.F.R. § 4.79 is the line "6040 Diabetic retinopathy", with no criteria, note or minimum attached. It sits under the General Rating Formula for Diseases of the Eye, so unlike glaucoma there is no 10 percent floor for medication. The formula opens with this sentence, word for word:
"General Rating Formula for Diseases of the Eye: Evaluate on the basis of either visual impairment due to the particular condition or on incapacitating episodes, whichever results in a higher evaluation"
| Rating | What it generally takes | Monthly pay (approx) |
|---|---|---|
| 60% | Documented incapacitating episodes requiring 7 or more treatment visits for an eye condition during the past 12 months. | ~$1,435/mo |
| 40% | At least 5 but less than 7 documented treatment visits (5 or 6) in the past 12 months. | ~$796/mo |
| 20% | At least 3 but less than 5 documented treatment visits (3 or 4) in the past 12 months. | ~$357/mo |
| 10% | At least 1 but less than 3 documented treatment visits (1 or 2) in the past 12 months. | ~$180/mo |
| 0% | No tier met, and corrected vision and visual fields not compensable: 0 percent under 38 C.F.R. § 4.31. A noncompensable retinopathy is considered part of the diabetic process under DC 7913, Note (1). | $0 |
The other route is vision. Corrected distance acuity is converted to a percentage through DC 6061 to 6066, and visual field loss through DC 6080 (visual field defects) and DC 6081 (scotoma), and VA assigns whichever route "results in a higher evaluation". A visit only for diagnostic, monitoring or screening purposes is not a treatment visit (M21-1 Part V, Subpart iii, Chapter 2, Section A, Block 1.f). Two one-eye rules are written for visual impairment: 38 C.F.R. § 4.75(d) caps the visual impairment of one eye at 30 percent unless the eye is anatomically lost, and 4.75(c) treats the other eye as 20/40 when visual impairment of only one eye is service connected, subject to 38 C.F.R. § 3.383(a). The text does not say how either rule applies to a rating on treatment visits.
Pay figures are approximate 2026 rates (effective December 1, 2025) for a single veteran with no dependents. Check VA.gov for current amounts.
How a diabetic retinopathy rating is decided
Two measurements run side by side, and the rater keeps the better one. These are the steps in the order the rules apply.
- 1
A treatment visit is a visit to treat
Note (1) of the formula defines an incapacitating episode as "an eye condition severe enough to require a clinic visit to a provider specifically for treatment purposes". Note (2) lists examples of treatment that "may include but are not limited to" systemic immunosuppressants or biologic agents, intravitreal or periocular injections, laser treatments, or other surgical interventions.
- 2
Count the treatment visits in the past 12 months
Documented treatment visits for an eye condition during the past 12 months set the 10, 20, 40 or 60 percent tier. The visits counted must be for the service-connected eye condition: 38 C.F.R. § 4.14 says "the use of manifestations not resulting from service-connected disease or injury in establishing the service-connected evaluation" is to be avoided. VA's manual adds that a clinic visit for diagnostic, monitoring or screening purposes is not sufficient, so an eye exam that only checks the retina adds nothing to the count.
- 3
Measure corrected vision and visual fields
The vision route uses corrected distance acuity (38 C.F.R. § 4.76) and, when there is a medical indication of disease or injury that may be associated with a visual field defect, visual field testing (4.75(b) and 4.77). If the examiner reports corrected near vision two or more scheduled steps worse than corrected distance vision, the distance figure is rated one step poorer than measured (4.76(b)(3)). When acuity and field loss are both present, the field defect is expressed as a level of acuity and the two are combined under 4.25. The examination must be done by a licensed optometrist or ophthalmologist (4.75(b)).
- 4
The higher of the two routes is assigned
The rater compares the two results and assigns the higher. If neither reaches 10 percent, 38 C.F.R. § 4.31 assigns 0 percent. Under Note (1) to DC 7913, a compensable retinopathy is evaluated separately from the diabetes unless it is part of the criteria used to support a 100 percent diabetes evaluation, and a noncompensable one is considered part of the diabetic process.
A stage on the medical scale is not a VA percentage. The formula looks only at visual impairment (visual acuity, visual field and muscle function, 38 C.F.R. § 4.75(a)) and documented treatment visits, so a proliferative diagnosis with no treatment visits in the past 12 months and vision that rates 0 percent meets no tier.
Making a VA Disability Claim for Diabetic Retinopathy
A VA claim for diabetic retinopathy as a complication of diabetes rests on four pieces of evidence:
A diagnosis
Diabetic retinopathy named as the diagnosis, for each affected eye, current during the claim, in your eye clinic records or on a VA eye examination.
Service-connected diabetes
Your diabetes is service connected, or a claim for the diabetes is filed and not yet decided. The retinopathy can reach service connection through the diabetes, not through a presumption of its own. The other route is aggravation: a retinopathy that is not service connected but was made worse by another service-connected condition, such as high blood pressure, under 38 C.F.R. § 3.310(b) (see the Aggravation pathway).
Evidence it is a diabetic complication
VA's manual: "Before conceding that a particular disability is a complication of diabetes, ensure that there is medical evidence of record supporting that determination" (M21-1 Part V, Subpart iii, Chapter 11, Block 2.b). An eye doctor's diagnosis of diabetic retinopathy, or an examiner's opinion, is medical evidence on that point.
Measurements for the percentage
Corrected acuity and visual fields measured on an examination by a licensed optometrist or ophthalmologist (38 C.F.R. § 4.75(b)), documented treatment visits in your eye clinic records, or both.
The standard of proof is the benefit of the doubt in 38 C.F.R. § 3.102: when the positive and negative evidence are in approximate balance, VA resolves the doubt for the veteran. The regulation describes that doubt as "a substantial doubt and one within the range of probability as distinguished from pure speculation or remote possibility." When your diabetes is service connected, an eye doctor has diagnosed diabetic retinopathy during your claim, no other eye examination has found it absent, and no examiner or decision has named another cause, the open question is the percentage, and that comes from your eye clinic records and the VA eye examination. A physician's opinion earns its place where the cause is disputed, where the diabetes claim itself is contested, or where an eye condition that came first has worsened.
Read our guide to when a nexus letter for diabetic retinopathy helps →
How to Connect Diabetic Retinopathy to Service
Diabetic retinopathy is not on any presumptive list in 38 C.F.R. § 3.309. Each route below runs through a service-connected condition: the diabetes in the first three tabs, and the diabetes or another service-connected condition in the aggravation tab. Which tab fits depends on where your diabetes claim stands and on what else is service connected.
When your diabetes is already service connected
VA's manual treats a newly claimed diabetic complication as a worsening of the diabetes, not as a fresh claim of its own.
- The filing lane. M21-1 Part V, Subpart iii, Chapter 11, Block 2.c concludes that "a claim asserting new complications of SC diabetes is a claim for increase rather than a claim for secondary SC."
- The effective date. Increases follow 38 C.F.R. § 3.400(o)(2): the earliest date it is factually ascertainable that the increase occurred, if a complete claim or intent to file a claim is received within 1 year from that date; otherwise, the date the claim is received.
- The depth. Our companion guide walks through this lane, the 0 percent fold-in under DC 7913, and when a medical opinion adds anything. Nexus letter for diabetic retinopathy secondary to diabetes →
Diabetes that showed up within a year of discharge
38 C.F.R. § 3.309(a) lists "Diabetes mellitus." among the chronic diseases that can be presumed service connected. The entry names no type.
- The window. Under 38 C.F.R. § 3.307(a)(3), the disease must have become manifest to a degree of 10 percent or more within 1 year from separation, after 90 days or more of service during a war period or after December 31, 1946 (3.307(a)(1)).
- The 10 percent level. On today's schedule the lowest row of DC 7913 is "Manageable by restricted diet only" at 10 percent, and it has read that way since June 6, 1996; we did not verify the wording before then. VA applies the version of the schedule in effect during the presumptive period (M21-1 Part V, Subpart ii, Chapter 2, Section B, Block 1.c).
- Diagnosis can come later. 3.307(c) does not require a diagnosis inside the year, only "characteristic manifestations of the disease to the required degree, followed without unreasonable time lapse by definite diagnosis", shown by "acceptable medical or lay evidence".
- The eyes. For a diabetes claim, VA's manual says "entitlement to any additional benefits based on complications would be considered within scope of the claim" (M21-1 Part V, Subpart iii, Chapter 11, Block 1.f), so a diagnosed retinopathy can be raised with the diabetes claim. It can be service connected as a complication once the diabetes is, on "medical evidence of record supporting that determination" (Block 2.b).
Herbicide exposure and type 2 diabetes
38 C.F.R. § 3.309(e) lists "Type 2 diabetes (also known as Type II diabetes mellitus or adult-onset diabetes)" among the diseases presumed service connected for a veteran exposed to an herbicide agent, when the requirements of 3.307(a)(6) are met.
- The diabetes, not the eyes. The word retinopathy does not appear anywhere in 3.309. The presumption covers the diabetes, and the retinopathy connects through it.
- Timing. For the herbicide list, 3.307(a)(6)(ii) requires the disease to have become manifest to a degree of 10 percent or more at any time after service.
- Type 1 diabetes. 3.309(e) names type 2 only. Type 1 diabetes can still reach service connection on another route, such as the one-year chronic-disease presumption in 3.309(a) or direct service connection under 3.303.
An eye condition made worse by a service-connected one
When a condition that is not service connected gets worse because of one that is, 38 C.F.R. § 3.310(b) can apply. That covers an eye disease that is not service connected, such as one that came before your diabetes, worsened by your service-connected diabetes, and a retinopathy that is not itself service connected but was worsened by another service-connected condition.
- The baseline comes first. VA will not concede aggravation unless the starting level of severity is shown. The regulation names medical evidence created before the worsening, or the earliest medical evidence after it. VA's manual adds "any other credible evidence, including lay evidence, that supports establishment of the baseline", notes that lay evidence alone may not be sufficient, and says that "if no baseline can be established, no aggravation can be demonstrated" (M21-1 Part V, Subpart ii, Chapter 2, Section D, Blocks 1.c and 1.f).
- The standard. The same manual section applies a but-for standard and says VA "will no longer consider natural progress of the NSC disability" in these claims (Block 1.a); the regulation's own text still mentions natural progress.
- One Board example, and what it was. In A25039119 (2025) the veteran had said his bilateral retinopathy was aggravated by his service-connected hypertension. The Board did not grant the claim. It remanded it because the VA opinion "focused strictly on the fact the Veteran's retinopathy is diabetic in nature" without considering whether it "may have been aggravated by the Veteran's hypertension (to include medications for hypertension)". Board decisions are "binding only with regard to the specific case decided" (38 CFR 20.1303).
Secondary Conditions
Diabetes is the cause of diabetic retinopathy, and high blood pressure is a risk factor for it. Retinopathy in turn can lead to other problems in the same eye. On the vision route those are measured on the same corrected vision and fields, and 38 C.F.R. § 4.14 bars evaluating "the same manifestation under different diagnoses", so same-eye conditions do not simply add. A mental health condition is rated under a different schedule.
Where diabetic retinopathy comes from
- Diabetes mellitus, type 1 or type 2. The cause. In a pooled analysis of 35 population studies, the prevalence of each retinopathy end point measured (any retinopathy, proliferative retinopathy, macular edema and vision-threatening retinopathy) increased with diabetes duration, HbA1c and blood pressure levels, and was higher in type 1 than in type 2 diabetes (PMID 22301125). For VA, a retinopathy claimed as a complication of the diabetes depends on the diabetes being service connected, on a diagnosis, and on medical evidence that it is a complication of that diabetes.
- High blood pressure. A risk factor, not the cause. A 2007 Lancet review states that high blood pressure "increases the risk of both development of diabetic retinopathy and its progression" (PMID 17276782). The two trials tested different targets in different groups: UKPDS 38, in people with type 2 diabetes and high blood pressure, found that a target below 150/85 reduced two-step worsening compared with a target below 180/105 (PMID 9732337), while ACCORD Eye, in people with type 2 diabetes at high cardiovascular risk, found that a systolic target below 120 did not slow progression compared with below 140 (PMID 20587587). For VA, worsening of a retinopathy that is not service connected by service-connected hypertension is a 3.310(b) question that needs a baseline.
Conditions that may go along with diabetic retinopathy
- Diabetic macular edema and vision loss. Swelling of the central retina can occur at any stage from mild nonproliferative to proliferative retinopathy (ADA 2026), and it is one path to lost central vision. The rating schedule has no code named for macular edema, and lost vision is measured through the vision route of the eye formula. The FAQ below covers how the Board decisions in our coding review handled it.
- Vitreous hemorrhage and retinal detachment. The ADA lists them among other ocular complications: "Other ocular complications include vitreous hemorrhage and tractional retinal detachment." The schedule's codes for intraocular hemorrhage (DC 6007) and detachment of retina (DC 6008) sit under the same formula, and in the same eye 4.14 bars rating the same lost vision twice. In A25023528 (2025) the Board counted treatment visits for a retinal detachment toward the retinopathy rating because a VA examiner tied the detachment to the retinopathy (non-precedential, 38 CFR 20.1303).
- Neovascular glaucoma. In proliferative retinopathy, abnormal new vessels can grow over the iris and the drainage angle, where they "can obstruct aqueous humor outflow and lead to increased intraocular pressure" (PMID 27895936). The schedule has no entry for neovascular glaucoma. Its glaucoma codes, 6012 and 6013, carry a 10 percent minimum when continuous medication is required, and which code fits this form is a question for the physician and the rater. Same-eye limits under 4.14 apply.
- Depression or anxiety with vision loss. A systematic review found the severity of diabetic retinopathy, macular edema and the vision loss they cause "significantly associated with poor psychosocial outcomes" (PMID 30879245), and a 2026 meta-analysis of 34 studies suggests a two-way association between diabetic retinopathy and depression, and found retinopathy associated with anxiety (PMID 42051445). A mental health claim under 38 C.F.R. § 3.310 needs its own medical evidence, and if granted it is rated under the mental disorders formula in 4.130, not the eye formula.
What to Gather - Evidence Checklist
Gather these before you file. For diabetic retinopathy, the percentage is set by dated eye clinic records and measured vision, so those come first.
Frequently Asked Questions
Why does my decision say DC 6006 instead of DC 6040?
DC 6040 is the rating schedule's code for diabetic retinopathy, added May 13, 2018. DC 6006 is the general code for retinopathy or maculopathy not otherwise specified, and it is the code retinopathy carried before that date. Both sit under the same General Rating Formula for Diseases of the Eye, so the code number by itself does not change the percentage. A page or decision that rates retinopathy under 38 C.F.R. § 4.84a is citing the eye schedule as it stood before December 10, 2008, the earlier of the two recent changes VA's manual lists (M21-1 Part V, Subpart iii, Chapter 2, Section A, Block 1.j); today's eye schedule is § 4.79, and the current eCFR has no § 4.84a. Under 38 C.F.R. § 4.27, a hyphenated code such as 6040-6066 or 6006-6066 is built with the disease first and, after the hyphen, the code that set the rating; 6066 is the central-visual-acuity code for vision of 10/200 or better in one eye. In a coding review we ran on Board decisions found by search, 20 are dated after May 13, 2018 and cite an eye code for diabetic retinopathy: 10 cite 6040 and 9 cite 6006, one of them both, and the other 2 cite neither. One of those 20 cites 6006-6066 for a 60 percent rating the Board set on treatment visits, so a decision's reasons, not its code line alone, show which route set the percentage. Board decisions are binding only with regard to the specific case decided (38 C.F.R. § 20.1303). VA's manual says service connection is not severed when the diagnostic code is corrected (M21-1 Part V, Subpart ii, Chapter 3, Section D, Block 1.e).
What happens at a VA eye exam for diabetic retinopathy?
Under 38 C.F.R. § 4.75(b), the examination "must be conducted by a licensed optometrist or by a licensed ophthalmologist", the examiner "must identify the disease, injury, or other pathologic process responsible for any visual impairment found", and, unless medically contraindicated, the back of the eye is examined with the pupils dilated. Uncorrected and corrected vision, for distance and near, is measured for each eye (4.76(a)), and visual fields are tested only when there is a medical indication of disease or injury that may be associated with a visual field defect. The findings go on VA's Eye Conditions Disability Benefits Questionnaire, which has a check box for diabetic retinopathy and asks for the number of documented treatment visits for an eye condition in the past 12 months. Bring or point to your eye clinic's treatment records, and describe your vision and your treatment exactly as they are.
Does diabetic macular edema get its own rating?
Not under a code of its own. The phrase "macular edema" does not appear anywhere in the rating schedule. Of the 20 Board decisions in our coding review (decisions found by search, dated after May 13, 2018, that cite an eye code for diabetic retinopathy), the six that named macular edema or maculopathy in the eye issue all rated it within the retinopathy, and none gave it a separate code. In A25002903 (2025), treatment visits for bilateral diabetic retinopathy with macula edema, including intravitreal injections every 4 to 6 weeks, supported 60 percent; in A26019674 (2026), mild nonproliferative retinopathy with macular edema, with no treatment visits and no impairment of visual acuity or visual field, was denied a separate compensable rating and stayed part of the diabetic process. Board decisions are binding only with regard to the specific case decided (38 C.F.R. § 20.1303). How VA regional offices code it is not public.
Can diabetic retinopathy lead to special monthly compensation?
It can, at severe levels of vision loss. 38 C.F.R. § 4.75(f) tells raters to check 38 C.F.R. § 3.350, and footnotes in the eye table flag the levels to review. Special monthly compensation under 38 U.S.C. 1114(k) covers blindness of one eye with only light perception, which 3.350(a)(4) describes as "inability to recognize test letters at 1 foot" when "perception of objects, hand movements, or counting fingers cannot be accomplished at 3 feet." Under 1114(l), "5/200 visual acuity or less bilaterally" qualifies, though an evaluation of 5/200 "based on acuity in excess of that degree but less than 10/200" does not (3.350(b)(2)), and "Concentric contraction of the field of vision beyond 5 degrees in both eyes is the equivalent of 5/200 visual acuity." Higher rates cover blindness in both eyes having only light perception, and anatomical loss of both eyes or blindness without light perception in both eyes. 4.75(f) adds that other levels of visual impairment combined with disabilities of other body systems may also establish entitlement.
Does it matter whether my diabetes is type 1 or type 2?
For the rules on this page, the type matters for one: the herbicide presumption. 38 C.F.R. § 3.309(e) names "Type 2 diabetes (also known as Type II diabetes mellitus or adult-onset diabetes)". The one-year chronic-disease list in 3.309(a) says only "Diabetes mellitus." with no type, and the diabetes rating code, DC 7913, rates diabetes mellitus without separating types. The eye rating does not depend on the type either: DC 6040 is rated on vision or treatment visits in both. A veteran with type 1 diabetes can reach service connection for the diabetes on another route, such as the one-year presumption or direct service connection, and a diagnosed retinopathy can be service connected as a complication of that diabetes, on medical evidence that it is one (M21-1 Part V, Subpart iii, Chapter 11, Block 2.b).
What changed in the 2018 eye rating rules?
VA's final rule at 83 FR 15316, effective May 13, 2018, added DC 6040 for diabetic retinopathy and retitled DC 6006 as retinopathy or maculopathy not otherwise specified. It also replaced the old incapacitating-episode test, which required prescribed bed rest and measured episodes in weeks, with the current count of treatment visits in the past 12 months. VA explained that a visit for diagnostic, monitoring or screening purposes "would only require time away from work for the visit itself." If a page or decision you read requires bed rest for an incapacitating eye episode, or measures eye episodes in weeks, it is drawing on the rule before May 13, 2018, which can still matter for a rating period before that date. VA's manual says the 2018 changes "were not liberalizing changes" and that changes in rating criteria "should not be the basis for a reduction in disability rating unless medical evidence establishes that the disability has actually improved."
My retinopathy got worse after I was rated. What now?
Ask VA for an increase. With the diabetes service connected, VA's manual also treats a new diabetic complication as a claim for increase rather than a claim for secondary service connection (M21-1 Part V, Subpart iii, Chapter 11, Block 2.c). The effective date follows 38 C.F.R. § 3.400(o)(2): the earliest date it is factually ascertainable that the increase occurred, if a complete claim or intent to file a claim is received within 1 year from that date; otherwise, the date VA receives the claim. The evidence is the same as for the first rating: dated treatment visits in the past 12 months, and current corrected acuity and fields. If the retinopathy was 0 percent and becomes compensable, Note (1) to DC 7913 has it evaluated separately from the diabetes unless it is part of the criteria used to support a 100 percent diabetes evaluation.
Do injections in both eyes on the same day count as two visits?
No rule we found answers this. The rating formula counts "treatment visits", VA's manual speaks of "a clinic visit to a provider specifically for treatment purposes", and the Eye Conditions DBQ asks for the number of documented medical visits for treatment. None of them says whether one visit with injections in both eyes counts once or twice, and none of the four Board decisions we read that discussed injections in both eyes decided it (Board decisions are binding only with regard to the specific case decided, 38 C.F.R. § 20.1303). We state no rule either way. In three of them the Board weighed treatment records together with the veteran's or a family member's statements; in the fourth it found no documented treatment visit, although the veteran reported laser treatments and injections, and denied a compensable rating. Records showing each visit date and what was done to each eye are the ones to keep.
Can diabetic retinopathy support a TDIU claim?
It can count toward one. If service-connected disabilities leave you unable to secure or follow a substantially gainful occupation, 38 C.F.R. § 4.16(a) allows a total rating when one disability is rated at 60 percent or more, or when one is at 40 percent or more and the combined rating is 70 percent or more. For that test, 4.16(a) counts "disabilities resulting from common etiology or a single accident" as one disability, and VA's manual applies that rule to a primary service-connected disability and the disabilities service connected as secondary to it or aggravated by it under 3.310 (M21-1 Part VIII, Subpart iv, Chapter 3, Section C, Block 4.a). 4.16(b) allows referral for extra-schedular consideration below those levels. We found no eye-specific TDIU rule in VA's manual.
Know Which Question Your Claim Is Really Asking
If your records show diabetic retinopathy diagnosed during your claim and service-connected diabetes, no other eye examination has found the retinopathy absent, and no one has named another cause, the open question is the rating, and your eye clinic's records answer it. A physician-written opinion can help where the record does not already link the retinopathy to the diabetes, where an examiner or decision has named another cause such as high blood pressure, or where an eye condition that came first has worsened. The consultation is free and gives you a straight answer on which applies. If you go ahead, a licensed clinician reviews your records after the $1,500 flat fee, and you get a refund before drafting if an honest opinion cannot be supported.
Sources & Regulatory References
- 38 CFR 4.79, Schedule of ratings, eye, including the General Rating Formula for Diseases of the Eye, DC 6006, DC 6040, DC 6061 to 6066, DC 6080 and DC 6081 (eCFR, issue date 2026-08-27) https://www.ecfr.gov/current/title-38/section-4.79
- 38 CFR 4.75, General considerations for evaluating visual impairment (eCFR, issue date 2026-08-27) https://www.ecfr.gov/current/title-38/section-4.75
- 38 CFR 4.76, Visual acuity (eCFR, issue date 2026-08-27) https://www.ecfr.gov/current/title-38/section-4.76
- 38 CFR 4.77, Visual fields (eCFR, issue date 2026-08-27) https://www.ecfr.gov/current/title-38/section-4.77
- 38 CFR 4.31, Zero percent evaluations (eCFR, issue date 2026-08-27) https://www.ecfr.gov/current/title-38/section-4.31
- 38 CFR 4.14, Avoidance of pyramiding (eCFR, issue date 2026-08-27) https://www.ecfr.gov/current/title-38/section-4.14
- 38 CFR 4.25, Combined ratings table (eCFR, issue date 2026-08-27) https://www.ecfr.gov/current/title-38/section-4.25
- 38 CFR 4.27, Use of diagnostic code numbers (eCFR, issue date 2026-08-27) https://www.ecfr.gov/current/title-38/section-4.27
- 38 CFR 4.119, Schedule of ratings, endocrine system, including DC 7913 and Note (1) (eCFR, issue date 2026-08-27) https://www.ecfr.gov/current/title-38/section-4.119
- 38 CFR 4.130, Schedule of ratings, mental disorders (eCFR, issue date 2026-08-27) https://www.ecfr.gov/current/title-38/section-4.130
- 38 CFR 4.16, Total disability ratings based on unemployability (eCFR, issue date 2026-08-27) https://www.ecfr.gov/current/title-38/section-4.16
- 38 CFR 3.102, Reasonable doubt (eCFR, issue date 2026-08-27) https://www.ecfr.gov/current/title-38/section-3.102
- 38 CFR 3.303, Principles relating to service connection (eCFR, issue date 2026-08-27) https://www.ecfr.gov/current/title-38/section-3.303
- 38 CFR 3.307, Presumptive service connection, including the chronic-disease and herbicide provisions (eCFR, issue date 2026-08-27) https://www.ecfr.gov/current/title-38/section-3.307
- 38 CFR 3.309, Diseases subject to presumptive service connection, paragraphs (a) and (e) (eCFR, issue date 2026-08-27) https://www.ecfr.gov/current/title-38/section-3.309
- 38 CFR 3.310, Secondary service connection and aggravation (eCFR, issue date 2026-08-27) https://www.ecfr.gov/current/title-38/section-3.310
- 38 CFR 3.350, Special monthly compensation ratings (eCFR, issue date 2026-08-27) https://www.ecfr.gov/current/title-38/section-3.350
- 38 CFR 3.383, Special consideration for paired organs and extremities (eCFR, issue date 2026-08-27) https://www.ecfr.gov/current/title-38/section-3.383
- 38 CFR 3.400, Effective dates, including paragraph (o)(2) (eCFR, issue date 2026-08-27) https://www.ecfr.gov/current/title-38/section-3.400
- 38 CFR 20.1303, Nonprecedential nature of Board decisions (eCFR) https://www.ecfr.gov/current/title-38/section-20.1303
- Schedule for Rating Disabilities: The Organs of Special Sense and Schedule of Ratings, Eye. Final rule, 83 FR 15316 (April 10, 2018), effective May 13, 2018 (Federal Register full text) https://www.federalregister.gov/documents/full_text/text/2018/04/10/2018-06928.txt
- Schedule for Rating Disabilities; Eye. Final rule, 73 FR 66543 (November 10, 2008), effective December 10, 2008, removing 38 CFR 4.83a and 4.84a (Federal Register full text) https://www.federalregister.gov/documents/full_text/text/2008/11/10/E8-26304.txt
- M21-1, Part V, Subpart iii, Chapter 2, Section A, Conditions of the Eyes, Blocks 1.f and 1.j (VA KnowVA, article 554400000014461) https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014461/M21-1-Part-V-Subpart-iii-Chapter-2-Section-A-Conditions-of-the-Eyes
- M21-1, Part V, Subpart iii, Chapter 11, Endocrine Conditions, Blocks 1.f, 2.b and 2.c (VA KnowVA, article 554400000180518) https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180518/M21-1-Part-V-Subpart-iii-Chapter-11-Endocrine-Conditions
- M21-1, Part V, Subpart ii, Chapter 2, Section D, Secondary Service Connection and Aggravation of Non-Service-Connected Disabilities, Blocks 1.a, 1.c and 1.f (VA KnowVA, article 554400000180484) https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180484/M21-1-Part-V-Subpart-ii-Chapter-2-Section-D-Secondary-Service-Connection-SC-and-Aggravation-of-Non-Service-Connected-NSC-Disabilities
- M21-1, Part V, Subpart ii, Chapter 3, Section D, Evaluating Disabilities, Block 1.e (VA KnowVA, article 554400000180489) https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180489/M21-1-Part-V-Subpart-ii-Chapter-3-Section-D-Evaluating-Disabilities
- M21-1, Part V, Subpart ii, Chapter 2, Section B, Presumptive Service Connection, Block 1.c (VA KnowVA, article 554400000180482) https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180482/M21-1-Part-V-Subpart-ii-Chapter-2-Section-B-Presumptive-Service-Connection-SC
- M21-1, Part VIII, Subpart iv, Chapter 5, Service Connection for Chronic Diseases, Block 1.e (VA KnowVA, article 554400000177482) https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177482/M21-1-Part-VIII-Subpart-iv-Chapter-5-Service-Connection-SC-for-Chronic-Diseases
- M21-1, Part VIII, Subpart iv, Chapter 3, Section C, Individual Unemployability Rating and Decision Review, Block 4.a (VA KnowVA, article 554400000177476) https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177476/M21-1-Part-VIII-Subpart-iv-Chapter-3-Section-C-Individual-Unemployability-IU-Rating-and-Decision-Review
- Public Disability Benefits Questionnaires, including the Eye Conditions Disability Benefits Questionnaire (VA) https://www.benefits.va.gov/compensation/dbq_publicdbqs.asp
- Eye Conditions Disability Benefits Questionnaire (VA, PDF) https://www.benefits.va.gov/compensation/docs/Eye_Conditions.pdf
- Individual Unemployability (VA.gov) https://www.va.gov/disability/eligibility/special-claims/unemployability/
- Diabetic Retinopathy (National Eye Institute, last updated September 11, 2025) https://www.nei.nih.gov/eye-health-information/eye-conditions-and-diseases/diabetic-retinopathy
- American Diabetes Association, Standards of Care in Diabetes-2026, Section 12: Retinopathy, Neuropathy, and Foot Care. Diabetes Care, 2026 (PMID 41358886; PMC full text) https://pmc.ncbi.nlm.nih.gov/articles/PMC12690177/
- Wilkinson CP, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003 (PubMed) https://pubmed.ncbi.nlm.nih.gov/13129861/
- Browning DJ, et al. Diabetic macular edema: Evidence-based management. Indian J Ophthalmol. 2018 (PubMed) https://pubmed.ncbi.nlm.nih.gov/30451174/
- Ashrafzadeh S, et al. Implementation of Teleretinal Screening Using Optical Coherence Tomography in the Veterans Health Administration. Telemed J E Health. 2021 (PubMed) https://pubmed.ncbi.nlm.nih.gov/34297906/
- Yau JW, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012 (PubMed) https://pubmed.ncbi.nlm.nih.gov/22301125/
- Wong TY, Mitchell P. The eye in hypertension. Lancet. 2007 (PubMed) https://pubmed.ncbi.nlm.nih.gov/17276782/
- UKPDS 38: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. BMJ, 1998 (PMID 9732337, PubMed) https://pubmed.ncbi.nlm.nih.gov/9732337/
- ACCORD Eye: Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med, 2010 (PMID 20587587, PubMed) https://pubmed.ncbi.nlm.nih.gov/20587587/
- Rodrigues GB, et al. Neovascular glaucoma: a review. Int J Retina Vitreous. 2016 (PubMed) https://pubmed.ncbi.nlm.nih.gov/27895936/
- Khoo K, et al. The relationship between diabetic retinopathy and psychosocial functioning: a systematic review. Qual Life Res. 2019 (PubMed) https://pubmed.ncbi.nlm.nih.gov/30879245/
- Fan S, et al. Bidirectional relationship of diabetic retinopathy with anxiety and depression: a meta-analysis. Front Endocrinol. 2026 (PubMed) https://pubmed.ncbi.nlm.nih.gov/42051445/
- Board of Veterans' Appeals, Citation Nr A25039119 (2025) https://www.va.gov/vetapp25/Files4/A25039119.txt
- Board of Veterans' Appeals, Citation Nr A25023528 (2025) https://www.va.gov/vetapp25/Files3/A25023528.txt
- Board of Veterans' Appeals, Citation Nr A25002903 (2025) https://www.va.gov/vetapp25/Files1/A25002903.txt
- Board of Veterans' Appeals, Citation Nr A26019674 (2026) https://www.va.gov/vetapp26/Files3/A26019674.txt
